SPOTLIGHT -
Article
Esketamine CIII Nasal Spray: First and Only Monotherapy for Treatment-Resistant Depression
Collaborative Approach to Treatment-Resistant Depression Management: A Q&A With Michael Asbach, DMSc, PA-C
Treating Our Young Patients: Psychotropic and Combination Therapies in the Youth
Lifestyle Interventions for ADHD
Research on Pause: COVID-19's Impact on Drug Development
Gauging ADHD Treatment Success: Improvement in Quality of Life